Internal Limiting Membrane Peeling-reposition to Treat Idiopathic Macular Holes

• Status: Completed
• Trial end date: 2019-08-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the morphologic and functional outcomes of internal limiting membrane peeling-reposition versus peeling in idiopathic macular holes

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Criteria

Inclusion Criteria:

• The patients are diagnosed as macular hole by optical coherence tomography.

• Age ranges from 50 to 80 years.

• The patients have indication for surgery.

Exclusion Criteria:

• Traumatic macular hole.

• Combined with serious epiretinal membrane.

• Combined with diabetic retinopathy, hypertensive retinopathy.

• Combined with other ocular diseases, such as keratitis，uveitis，retinal vasculitis.

• - 6.0 diopters or more of spherical equivalent, 26mm or more of axial length.

• History of intraocular surgery.

• Presence of staphyloma.

• Other ocular diseases that could influence macular microstructure or visual function

Exit criteria:

• For reposition group, the patients will exit the research if the peeled ILM cannot reposition successfully.

• Due to adverse events, especially severe adverse events, the researchers consider withdrawal of patients based on concerns of safety and ethics;

• Drop out;

• The patients voluntarily withdraw the informed consent;

• Serious violation of the study protocol due to the subjects or investigators' reasons;

• Other reasons that the researchers believe for quitting the study.